| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7fe23d6754a4999c6cbe01c3dd82b445 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2030-027 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-045
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-11
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N30-74
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-095 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N30-02 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-095
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N30-74
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-045
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-12 |
| filingDate |
2017-08-28^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2018-06-12^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3a0227b84f24f8d58f6aeebdd9c713fb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9c534cd027244f37c46c9936fe65bb41
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f9ecaaf8d05f4d06674177f7e2615c99
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_02e34338e2145700bb2c457a81ca4eb1 |
| publicationDate |
2018-06-12^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-9993520-B2 |
| titleOfInvention |
Vasopressin formulations for use in treatment of hypotension |
| abstract |
Provided herein are peptide formulations comprising polymers as stabilizing agents. The peptide formulations can be more stable for prolonged periods of time at temperatures higher than room temperature when formulated with the polymers. The polymers used in the present invention can decrease the degradation of the constituent peptides of the peptide formulations. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11135265-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2022133838-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11207372-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2019192616-A1 |
| priorityDate |
2015-01-30^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |